Abstract
Unraveling the function of the mammalian genome relies heavily on analyses of the laboratory mouse. Because of its powerful genetics and available technologies to manipulate the genome, plus its developmental and physiological similarities to humans, it has become a goal to generate mutations in all mouse genes and analyze the phenotypic consequences. Gene targeting in embryonic stem (ES) cells is the method of choice for making null mutations in known genes of interest. However, forward genetics approaches, in which mutations are produced randomly throughout the genome, has the advantage of producing alleles of varying severity both within known genes, in non-coding regulatory elements, or in other unannotated functional elements. Such forward genetic mutation screens in mice have typically involved treating male mice with N-ethyl-N-nitrosourea (ENU), followed by three generations of breeding to render potential recessive mutations homozygous, at which time phenotype screens can be performed. An alternative strategy for randomly mutagenizing the mouse genome is by chemical treatment of ES cells. This enables the use of multiple alternative chemicals with different mutational spectra, can reduce breeding to two generations, and impart a higher mutational load. Furthermore, ES cell mutagenesis can be used to create banks of clones that can be screened for point mutations in genes of interest, and to conduct forward genetic screens in vitro to detect potential phenotypes prior to generation of mice. In this chapter, we provide a detailed protocol for mutagenizing ES cells with the point mutagen ethylmethanesulfonate (EMS).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Russell W, Kelly E, Hunsicker P, Bangham J, Maddux C, Phipps E. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA 1979;76:5818–9.
Munroe RJ, Bergstrom RA, Zheng QY, et al. Mouse mutants from chemically mutagenized embryonic stem cells. Nat Genet 2000;24:318–21.
Browning VL, Chaudhry SS, Planchart A, Dixon MJ, Schimenti JC. Mutations of the mouse Twist and sy (fibrillin 2) genes induced by chemical mutagenesis of ES cells. Genomics 2001;73:291–8.
Vivian JL, Chen Y, Yee D, Schneider E, Magnuson T. An allelic series of mutations in Smad2 and Smad4 identified in a genotype-based screen of N-ethyl-N-nitrosourea-mutagenized mouse embryonic stem cells. Proc Natl Acad Sci USA 2002;99:15542–7.
Chen Y, Yee D, Dains K, et al. Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet 2000;24:314–7.
Ward JO, Reinholdt LG, Hartford SA, et al. Toward the genetics of mammalian reproduction: induction and mapping of gametogenesis mutants in mice. Biol Reprod 2003;69:1615–25.
Greber B, Lehrach H, Himmelbauer H. Characterization of trimethylpsoralen as a mutagen for mouse embryonic stem cells. Mutation Res 2003;525:67–76.
Munroe RJ, Ackerman SL, Schimenti J. Genome-wide two generation screens for recessive mutations by ES cell mutagenesis. Mamm Genome 2004;15:960–5.
Chen Y, Schimenti J, Magnuson T. Toward the yeastification of mouse genetics: chemical mutagenesis of embryonic stem cells. Mamm Genome 2000;11:598–602.
Robertson E. Embryo-derived stem cell lines. In: Robertson E, ed. Teratocarcinomas and embryonic stem cells a practical approach. Oxford: IRL Press; 1987;71–112.
Tessarollo L. Manipulating mouse embryonic stem cells. Methods Mol Biol. (Clifton, NJ) 2001;158:47–63.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Munroe, R., Schimenti, J. (2009). Mutagenesis of Mouse Embryonic Stem Cells with Ethylmethanesulfonate. In: Wurst, W., Kühn, R. (eds) Gene Knockout Protocols. Methods in Molecular Biology, vol 530. Humana Press. https://doi.org/10.1007/978-1-59745-471-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-471-1_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-934115-26-8
Online ISBN: 978-1-59745-471-1
eBook Packages: Springer Protocols